CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 7 enrolled / 7 target
Drug / intervention
Intralesional administration of 5-fluorouracildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07397520
NCT07397520Phase 4CompletedOn Track (0.6/mo)Completion was 7mo ago

The Application of Intralesional 5-fluorouracil for the Management of Hypertrophic Facial Scars in the Periocular Region Resulting From Trauma and Surgical Procedures in Individuals Aged Over 18 Years

Instituto de Oftalmología Fundación Conde de Valenciana·interventional·Posted Feb 9, 2026·Updated Jun 25, 2026

In Brief

A Phase 4 clinical trial evaluating Intralesional administration of 5-fluorouracil for Facial Scarring. Completed, enrolled 7 participants across 1 site.

Detailed Summary

To determine the effectiveness of intralesional 5-fluorouracil in objectively reversing hypertrophic scars in the periocular region resulting from trauma or cosmetic surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFacial Scarring
CountriesMexico
Collaborators--

Timeline

Phase 4CompletedFinished
2026
First PostedFeb 9, 2026
Enrollment StartAug 1, 2025
Primary CompletionNov 28, 2025
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5 months ago

Arms & Interventions

Intralesional administration of 5-fluorouracil will be conducted in the periocular scar groupexperimental

For the objective assessment of baseline status and subsequent facial skin changes, the validated Manchester Scar Scale will be used, which is a visual photonumeric scale for evaluating scar quality. This scale assesses six skin parameters, such as color, contour, distortion, texture, and brightness, assigning values from 1 to 4, with 1 indicating the best characteristic and 4 the least desirable.

Drug: Intralesional administration of 5-fluorouracil

Interventions

Intralesional administration of 5-fluorouracildrug

For the objective assessment of baseline status and subsequent facial skin changes, the validated Manchester Scar Scale will be used, which is a visual photonumeric scale for evaluating scar quality. This scale assesses six skin parameters, such as color, contour, distortion, texture, and brightness, assigning values from 1 to 4, with 1 indicating the best characteristic and 4 the least desirable